PLEASE SELECT THE DESTINATION COUNTRY AND LANGUAGE :
KANZEN R&D
Kanzen's R&D network verified with differentiated core technology and research results
Through continuous research and development of Kanzen R&D Center, we have applied
for and Registration 12 domestic technology patents in the fields of medicine and cosmetics.
| Name | Patent Number | Application Date | Category |
|---|---|---|---|
| Use as beta-lactamase inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) or its derivatives |
10-1953981 | 17.07.24 | Registration 19.02.25 |
| Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and screening method for detecting the same |
10-1877002 | 17.10.11 | Registration 18.07.04 |
| Peptide binding to trans-2-nonenal and aldehyde-based odor removal composition comprising the above peptide |
10-1993987 | 17.10.11 | Registration 19.06.21 |
| Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and screening method for detecting the same |
10-1867779 | 17.12.08 | Registration 18.06.07 |
| Composition comprising botulinum toxin and method for preparing same |
10-2247924 | 19.04.18 | Registration 21.04.28 |
| Composition comprising botulinum toxin and method for preparing same Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and method for detecting the same | 16/491,499 (Entry number) |
19.09.05 | |
| Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and screening method for detecting the same | 201580050749.X (Entry number) |
19.09.06 | Submission of opinion supplementary statement |
| Composition comprising botulinum toxin and method for preparing same Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and method for detecting the same | 18764324.2 (Entry number) |
19.10.04 | Submission of opinion supplementary statement |
| Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and method for detecting the same | 10-2017-28220 (Entry number) |
19.11.06 | |
| Novel cell-penetrating peptides and uses thereof | 10-2192191 | 19.12.06 | Registration 20.12.17 |
| Recombinant protein comprising botulinum toxin and cell-penetrating peptide and cosmetic composition comprising the same | 10-2192192 | 20.08.07 | Registration 20.12.17 |
| Hyaluronic acid production strain and hyaluronic acid production method using the same | 10-2249438 | 20.09.25 | Registration 21.04.30 |
By combining with existing materials that were difficult
to penetrate into the skin, CDP technology with amazing penetrating power
suggests various skin penetrating application technologies.
We lead the bio skin care industry as a leader in skin penetration applications
through the combination of Kanzen's genetic recombination technology and CDP technology,
such as natural moisturizing factor (PGA), skin regeneration factor (EGF), and skin cell growth factor (IGF).
「Ministry of Science and ICT, 2022 Bio Risk Assessment One Team Renovation Project」
「Ministry of SMEs and Startups, 2022 Technology Development Innovation Project」
Skin antioxidant effect
Cell protection, wrinkle regeneration, skin tone improvement, whitening
Skin cell growth
Collagen generation,
Skin regeneration
promotion of epithelial cell growth,
Production of skin natural moisturizing factor
Skin moisturizing,
Copyright © 2022 kanzencosmedical. All rights reserved.
02-876-4633
kanzencosmedical@kanzen.co.kr
PLEASE SELECT THE DESTINATION COUNTRY AND LANGUAGE :
